chr5-33982344-A-G
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PM1PM2PP5_Very_Strong
The NM_016180.5(SLC45A2):c.454T>C(p.Phe152Leu) variant causes a missense change. The variant allele was found at a frequency of 0.00000929 in 1,614,074 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_016180.5 missense
Scores
Clinical Significance
Conservation
Publications
- oculocutaneous albinism type 4Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SLC45A2 | NM_016180.5 | c.454T>C | p.Phe152Leu | missense_variant | Exon 2 of 7 | ENST00000296589.9 | NP_057264.4 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SLC45A2 | ENST00000296589.9 | c.454T>C | p.Phe152Leu | missense_variant | Exon 2 of 7 | 1 | NM_016180.5 | ENSP00000296589.4 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152194Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000159 AC: 4AN: 251460 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461880Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 8AN XY: 727242 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152194Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74348 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
- -
Oculocutaneous albinism type 4 Pathogenic:1
Variant summary: SLC45A2 c.454T>C (p.Phe152Leu) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 1.6e-05 in 251460 control chromosomes. c.454T>C has been reported in the literature in compound heterozygous individuals affected with Oculocutaneous albinism type 4 (example: Lasseaux_2018, Loftus_2023, Internal data). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 29345414, 37327787). ClinVar contains an entry for this variant (Variation ID: 521030). Based on the evidence outlined above, the variant was classified as likely pathogenic. -
not provided Pathogenic:1
This sequence change replaces phenylalanine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 152 of the SLC45A2 protein (p.Phe152Leu). This variant is present in population databases (rs202120684, gnomAD 0.004%). This missense change has been observed in individual(s) with SLC45A2-related conditions (PMID: 29345414; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 521030). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SLC45A2 protein function with a negative predictive value of 80%. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
SLC45A2-related disorder Uncertain:1
The SLC45A2 c.454T>C variant is predicted to result in the amino acid substitution p.Phe152Leu. This variant has been reported along with a frameshift variant in SLC45A2 in an individual with oculocutaneous albinism (Table S5, Lasseaux et al. 2018. PubMed ID: 29345414). This variant is reported in 0.0040% of alleles in individuals of African descent in gnomAD. Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at